Embracing Obesity in Collaboration -- Why, When, and How to Intervene

Introduction/Overview

Obesity as a Risk Factor for a Number of Disease States and Risk Factors

Obesity Is an Important Contributor to Progression of Osteoarthritis: Knee OA

Weight Loss With Liraglutide in Patients With Obesity and Mood Disorders

Life Expectancy Decreases as BMI Increases

Location of Excess Body Fat May Have a Larger Impact on Metabolic Health Than Fat Quantity

EASO Guidelines for Obesity Management in Primary Care

The Conversation: Why Do You Eat?

Reciprocal Signaling Between Cancer-Associated Adipocytes and Cancer Cells

Avoid Stigmatization of the Patient With Obesity

Weight Loss Improves Obesity-Related CV Comorbidities

Obesity: Imbalance of Energy Regulation, Not a Failure of Willpower

Pooled Estimates Of Incidence Depression Leading To Obesity, Relative And Absolute Risk

The "5 A's" of Obesity Counseling in Canadian Primary Care

Trust and Perceived Negative Judgment: Primary Care Physicians

Chronic Care Management of Patients With Obesity: the Multidisciplinary Team

Available Weight Loss Agents

Orlistat-Induced Weight Loss and Maintenance at 1 Year

SCALE Maintenance (Liraglutide 3 SCALE Maintenance (Liraglutide 3.0 mg): Proportion of Patients Maintaining Run-In Weight Loss or Regaining ≥ 5% From Randomization to Week 56

Naltrexone + Bupropion vs Placebo: Results From The COR-I Trial

Bariatric Surgery Is Associated With Sustained Weight Loss Over 15 Years

Anemia and Nutritional Deficiencies Associated With Roux-en-Y Bariatric Surgery

Summary and Conclusions

Abbreviations